caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1265669600

Melinda YushakM.D., M.P.H.

Hematology-OncologyNew Haven, CTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 110010
Hospital
CCN 110078
Hospital
CCN 110082
Hospital
CCN 110230
Hospital
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
80.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity
REFERRAL NETWORK

Where Melinda Yushak's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
YALE NEW HAVEN HOSPITAL1847
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
242
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
10
Brand share
70.2%
Top prescribed drugs
Encorafenib50 claims
Binimetinib48 claims
Ondansetron Hcl22 claims
Trametinib Dimethyl Sulfoxide22 claims
Gabapentin20 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
121
Unique beneficiaries
—
Total services
180
Distinct HCPCS
3
Medicare payment
$16K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 119 Hematology-Oncology providers in CT — bottom quintile (cohort median 735).